Ziopharm Oncology
ZIOP
#8592
Rank
โ‚น16.79 B
Marketcap
โ‚น78.08
Share price
-0.88%
Change (1 day)
-73.53%
Change (1 year)

Revenue for Ziopharm Oncology (ZIOP)

Revenue in 2021 (TTM): โ‚น0.24 Billion

According to Ziopharm Oncology's latest financial reports the company's current revenue is โ‚น0.33 Billion. In 2017 the company made a revenue of โ‚น0.57 Billion a decrease over the revenue in the year 2016 that were of โ‚น0.61 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ziopharm Oncology from 2001 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚น0.24 B
2017โ‚น0.57 B-6.88%
2016โ‚น0.61 B58.38%
2015โ‚น0.38 B215.51%
2014โ‚น0.12 B71.63%
2013โ‚น71.79 M0%
2012โ‚น71.79 M19.94%
2011โ‚น59.86 M
2001โ‚น0.15 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚น3.228 T 961,948.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.310 T 1,284,575.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
โ‚น56.7 M-83.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚น989.27 B 294,711.45%๐Ÿ‡บ๐Ÿ‡ธ USA